Insider filing
Traded Oct 9 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LBRX · NASDAQ · Pharmaceutical Preparations
Lb Pharmaceuticals (LBRX) · oqro.io/stocks/LBRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$38.85−1.19 (−2.97%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Including 2 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Oct 9 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Oct 9 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Sep 12, 2025 · filed 4 days later
A major shareholder of Lb Pharmaceuticals paid $15M out of pocket for Lb Pharmaceuticals shares. 3 other people at Lb Pharmaceuticals bought some too, in the same month. Shares held went up 243% with this purchase.
Traded Sep 12, 2025 · largest single transaction ~$30M
Sep 12, 2025~$30M · 2M sh @ $15.00
DetailsOfficial recordInsider buying
Traded Sep 12, 2025 · filed 4 days later
A Lb Pharmaceuticals director paid $15M out of pocket for Lb Pharmaceuticals shares. 3 other people at Lb Pharmaceuticals bought some too, in the same month. Shares held went up 243% with this purchase.
Traded Sep 12, 2025 · largest single transaction ~$4.99M
Sep 12, 2025~$4.99M · 333K sh @ $15.00
DetailsOfficial recordSep 12, 2025~$10M · 667K sh @ $15.00
DetailsOfficial recordSep 12, 2025~$12K · 767 sh @ $15.00
DetailsOfficial record0 open-market purchases and 0 open-market sales by insiders of LBRX between Feb 24, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 10, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | None | None | None |
| Aug 11, 2026 | None | None | None |
| May 12, 2026 | None | None | None |
| Mar 26, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies